Criticalkare Pharma

Myltega Tablet is an antiviral drug belonging to the Integrase strand transfer inhibitor category, containing the active ingredient Dolutegravir. It is used to treat human immunodeficiency virus (HIV) infection. HIV infection is mainly spread by sexual contact with anyone who has the infection or by transfer of infected blood (by sharing injection needles). This drug must be taken with other medicines used to treat HIV infection.
This drug is contraindicated in individuals with liver disease. Due to the higher concentration, caution should be taken when administering the drug to individuals with liver impairment. The dosage of this drug may need to be adjusted by your doctor, or it may need to be used with extra monitoring in these individuals to ensure its safety and efficacy. During the early stages of HIV treatment, some patients may experience an inflammatory response to opportunistic infections. This condition, immune reconstitution syndrome, can occur after starting the drug or other antiretroviral therapies. Knowing this possibility and monitoring for any signs of worsening infections or inflammatory symptoms is necessary. Inform your healthcare provider if the symptoms concern you or persist longer than usual.

Uses
Human Immunodeficiency Virus (HIV)

Storage
Store Myltega Tablet at room temperature (15°to 25°C).

Side Effects
Allergic reactions (swelling, high temperature)Infection, inflammationInflammation of the liver; liver failureJoint painDepressionAbnormal dreams, insomniaItching, rashBeing sickStomach discomfort, painHeadacheDiarrheaFatigue